Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

PROCEPT BioRobotics (PRCT) Accumulated Depreciation & Amortization (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $6.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 22.09% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.4 million, a 22.09% increase, with the full-year FY2025 number at $6.4 million, up 22.09% from a year prior.
  • Accumulated Depreciation & Amortization was $6.4 million for Q4 2025 at PROCEPT BioRobotics, up from $4.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $6.4 million in Q4 2025 to a low of $758000.0 in Q1 2022.
  • A 5-year average of $2.7 million and a median of $2.5 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: fell 17.16% in 2022, then soared 70.94% in 2024.
  • PROCEPT BioRobotics' Accumulated Depreciation & Amortization stood at $3.3 million in 2021, then decreased by 14.53% to $2.8 million in 2022, then soared by 34.0% to $3.8 million in 2023, then surged by 37.48% to $5.2 million in 2024, then rose by 22.09% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Accumulated Depreciation & Amortization are $6.4 million (Q4 2025), $4.7 million (Q3 2025), and $3.1 million (Q2 2025).